Current evidence for the diagnostic value of gadoxetic acid-enhanced magnetic resonance imaging for liver metastasis (Q38691844)

5 September 2017

title

Current evidence for the diagnostic value of gadoxetic acid-enhanced magnetic resonance imaging for liver metastasis (English)

1 reference

5 September 2017

Masakatsu Tsurusaki

1

1 reference

5 September 2017

Keitaro Sofue

series ordinal

2

1 reference

5 September 2017

Takamichi Murakami

series ordinal

3

1 reference

5 September 2017

publication date

9 January 2016

1 reference

5 September 2017

1 reference

5 September 2017

volume

46

1 reference

5 September 2017

issue

9

1 reference

5 September 2017

page(s)

853-861

1 reference

ACR Appropriateness Criteria pretreatment staging of colorectal cancer

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Benefits and safety of hepatic resection for colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Comparison of MR and PET imaging for the evaluation of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Update on the role of imaging in management of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Abdominal MR imaging at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Liver MR imaging: 1.5T versus 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

3.0-T MRI evaluation of patients with chronic liver diseases: initial observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

3.0-T MR imaging of the abdomen: comparison with 1.5 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Abdominal applications of diffusion-weighted magnetic resonance imaging: Where do we stand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Diffusion-weighted imaging of biliopancreatic disorders: correlation with conventional magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Hepatic metastases: use of diffusion-weighted echo-planar imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Segment-oriented approach to liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12646

21 January 2018

Identifiers

DOI

10.1111/HEPR.12646

1 reference

5 September 2017

1 reference